Aeon Biopharma, INC. (AEON) — 10-K Filings
All 10-K filings from Aeon Biopharma, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
AEON Biopharma Files 2024 10-K, Details Financials
— Mar 24, 2025 Risk: medium
AEON Biopharma, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as Priveterra Acquisition Corp., reported various -
AEON Biopharma, Inc. Files 2023 Annual Report on Form 10-K
— Mar 29, 2024 Risk: low
AEON Biopharma, Inc. (AEON) filed a Annual Report (10-K) with the SEC on March 29, 2024. AEON Biopharma, Inc. filed its annual report for the fiscal year ended
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX